Ładuje się......
Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization
AIM: To investigate the incidence of abrupt visual loss and its associated factors, during anti-vascular endothelial growth factor (VEGF) treatment for type 3 neovascularization. METHODS: This retrospective study included 137 eyes that were newly diagnosed with type 3 neovascularization. All eyes we...
Zapisane w:
| Wydane w: | Int J Ophthalmol |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
International Journal of Ophthalmology Press
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6423401/ https://ncbi.nlm.nih.gov/pubmed/30918819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18240/ijo.2019.03.20 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|